An innovative cardiovascular start-up, HDAX Therapeutics, is the latest company to win $250,000 in funding following another year of the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) program. The ECHO program...
Several members of the Ted Rogers Centre for Heart Research (TRCHR) participated in Vascular 2023, a five-day conference held in Montreal from October 25-29. The conference is a hallmark event organized by several Canadian specialist and research organizations,...
Researchers at the Ted Rogers Centre for Heart Research have developed an innovative approach to better understanding the complex signaling mechanisms underlying heart failure. A recent publication in the Proceedings of the National Academy of Sciences (PNAS) offers...
The Rogers Foundation announces a second landmark gift, building on its $130 million gift in 2014, to sustain the Ted Rogers Centre for Heart Research in perpetuity and bring the promise of precision cardiac health to patients across Canada and globally. In 2014, the...
Ted Rogers Chair in Heart Function Outcomes Dr. Douglas Lee leads new Heart-Brain Connection $3 million IMPACT Award project
Four unique educational events in October and December
Join us Thursday, October 12, 2023 for ECHO PITCH, a special event where six top cardiovascular health start-ups compete for funding from a $250,000 pool in front of a panel […]
We’re bringing together a multi-disciplinary community of researchers, clinicians, and engineers, to share the latest discoveries, insights, and innovations in cardiovascular science, with a focus on heart failure. You can […]
We are thrilled to host our 7th annual Heart Failure Symposium this December, an event open to participants in person as well as online. Our symposium blends clinical innovations with […]
